Insider Transactions in Q2 2021 at Five Prime Therapeutics, Inc. (FPRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 16
2021
|
Thomas Civik President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
68,971
-100.0%
|
$2,620,898
$38.0 P/Share
|
|
Apr 16
2021
|
Franklin M Berger Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-100.0%
|
$190,000
$38.0 P/Share
|
|
Apr 16
2021
|
David White Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,423
-100.0%
|
$1,270,074
$38.0 P/Share
|
|
Apr 16
2021
|
David V Smith Executive Vice President & CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
138,947
-100.0%
|
$5,279,986
$38.0 P/Share
|
|
Apr 16
2021
|
David V Smith Executive Vice President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
66,000
+32.2%
|
-
|
|
Apr 16
2021
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,385
-100.0%
|
$90,630
$38.0 P/Share
|
|
Apr 16
2021
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
169,468
-100.0%
|
$6,439,784
$38.0 P/Share
|
|
Apr 16
2021
|
Francis Willard Sarena Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,000
+28.03%
|
-
|
|
Apr 16
2021
|
Helen Louise Collins EVP and Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
135,547
-100.0%
|
$5,150,786
$38.0 P/Share
|
|
Apr 16
2021
|
Helen Louise Collins EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,000
+32.75%
|
-
|
|
Apr 09
2021
|
Thomas Civik President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,088
-13.85%
|
$410,256
$37.94 P/Share
|
|
Apr 06
2021
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Bona fide gift
|
Direct |
14,174
-12.05%
|
-
|
|
Apr 05
2021
|
William R Ringo Director |
SELL
Bona fide gift
|
Direct |
10,000
-100.0%
|
-
|
|
Apr 05
2021
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Bona fide gift
|
Direct |
2,460
-2.05%
|
-
|
|
Apr 01
2021
|
Francis Willard Sarena Chief Strategy Officer |
SELL
Bona fide gift
|
Direct |
3,825
-1.55%
|
-
|
|
Apr 01
2021
|
Francis Willard Sarena Chief Strategy Officer |
BUY
Bona fide gift
|
Indirect |
2,385
+50.0%
|
-
|